Vistagen Therapeutics (VTGN) Preferred Dividend Payments (2015 - 2021)
Vistagen Therapeutics (VTGN) posted Preferred Dividend Payments of $208000.0 for Q4 2021, down 44.53% sequentially from $375000.0 in Q3 2021, and down 41.18% YoY from $353600.0 in Q4 2020.
Vistagen Therapeutics (VTGN) Preferred Dividend Payments (2015 - 2021) Analysis & Trends
Vistagen Therapeutics has reported Preferred Dividend Payments for 7 years, with the latest figure at $208000.0 in Q4 2021.
- Quarterly Preferred Dividend Payments fell 41.18% year-over-year to $208000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $208000.0 (down 85.55% YoY) and the FY2022 annual result came in at $945100.0, down 31.79% from the prior year.
- Preferred Dividend Payments declined to $208000.0 in Q4 2021 per VTGN's latest filing, from $375000.0 in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $375000.0 in Q3 2021 and troughed at $208000.0 in Q4 2021.
- A 5-year average of $305206.2 and a median of $308150.0 in 2019 frame the typical range for Preferred Dividend Payments.
- The sharpest annual moves came in 2017 and 2021: Preferred Dividend Payments surged 122.59% in 2017, then tumbled 41.18% in 2021.
- Over 5 years, Preferred Dividend Payments stood at $263000.0 in 2017, then climbed by 10.61% to $290900.0 in 2018, then climbed by 10.62% to $321800.0 in 2019, then climbed by 9.88% to $353600.0 in 2020, then sank by 41.18% to $208000.0 in 2021.
- According to Business Quant data, Preferred Dividend Payments over the past three periods registered $208000.0, $375000.0, and $362000.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Vistagen Therapeutics | 10.49 Mn | 10.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 208,000.00 |
| Sep 30, 2021 | 375,000.00 |
| Jun 30, 2021 | 362,000.00 |
| Mar 31, 2021 | 349,000.00 |
| Dec 31, 2020 | 353,600.00 |
| Sep 30, 2020 | 347,200.00 |
| Jun 30, 2020 | 335,800.00 |
| Dec 31, 2019 | 321,800.00 |
| Sep 30, 2019 | 313,800.00 |
| Jun 30, 2019 | 302,500.00 |
| Dec 31, 2018 | 290,900.00 |
| Sep 30, 2018 | 283,600.00 |
| Jun 30, 2018 | 273,500.00 |
| Dec 31, 2017 | 263,000.00 |
| Sep 30, 2017 | 256,300.00 |
| Jun 30, 2017 | 247,300.00 |
| Jun 30, 2016 | 111,100.00 |
| Dec 31, 2015 | -668,700.00 |
| Sep 30, 2015 | -886,900.00 |
| Jun 30, 2015 | -213,300.00 |